BSE Live
Oct 31, 16:01Prev. Close
1619.20
Open Price
1623.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:56Prev. Close
1619.90
Open Price
1627.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Eris Lifesciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 323.59 | 311.78 | 311.89 | 273.99 | 153.93 | |
| Net CashFlow From Operating Activities | 265.19 | 216.31 | 236.28 | 209.72 | 132.65 | |
| Net Cash Used In Investing Activities | 126.80 | 2.08 | -592.73 | -198.67 | -45.39 | |
| Net Cash Used From Financing Activities | -333.52 | -220.74 | 363.26 | -17.52 | -83.70 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 58.47 | -2.34 | 6.81 | -6.48 | 3.57 | |
| Cash And Cash Equivalents Begin of Year | 6.46 | 8.81 | 2.00 | 8.48 | 4.91 | |
| Cash And Cash Equivalents End Of Year | 64.93 | 6.46 | 8.81 | 2.00 | 8.48 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher